About
2,959.50JPY-21.50 -0.72%
Closed • Updated at 17:44 GMT+00:00Market Cap$16.37B
P/E Ratio12.28
Volume2.66M
Beta0.56
RSI33.51
Gross Margin82.28%
Shionogi & Co., Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats
Apr 7 2026
ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-Producing Enterobacterales Infections
Apr 1 2026
Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)
Mar 24 2026
Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109
Mar 18 2026
BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025
Community Chat
Ask AI
Try asking
Translate